OneVentures leads $20 million Kira Biotech fundraising

BRISBANE: A new Queensland-based biotech company developing therapies for challenging immune system disorders has scored $20 million in funding from OneVentures and IP Group, along with the Advance Queensland Business Development Fund.

Born from research conducted by Professor Derek Hart and Associate Professor Georgina Clark, Kira Biotech is now led by former 20-year Janssen executive Dr Dan Baker.